OB/GYN Clinical Alert – April 1, 2007
April 1, 2007
View Issues
-
Management of Ovarian Torsion
In this retrospective study, the authors gleaned hospital records to identify cases of adnexal torsion at their hospital in Israel between 2002 and 2006. Sixty-two cases were found appropriate for the study. -
Does Cervical Conization Predispose a Patient to Preterm Birth?
It has not been clear as to whether a cervical conization truly predisposes a patient to preterm birth (PTB). The authors of this enlightening paper set out to see if the interval between the procedure and subsequent conception had any effect on the incidence of PTB. -
Clomiphene, Metformin, or Both
Legro and colleagues, reporting for the Cooperative Multicenter Reproductive Medicine Network, presented the results of a multicenter, randomized trial indicating that clomiphene is superior to metformin in achieving live births in women with the polycystic ovary (PCO) syndrome. -
EVRA and Venous Thrombosis — Part II
Cole and colleagues from i3 Drug Safety reported that the use of the transdermal contraceptive system was associated with a 2.4-fold increase in the risk of venous thromboembolism compared with users of a 35 µg ethinyl estradiol and norgestimate oral contraceptive.1 i3 Drug Safety is a unit of Ingenix, a medical information company owned by United Health Group. -
Using Gabapentin for Vulvodynia
This retrospective chart review covered all patients with vulvodynia treated with gabapentin at a single facility between January of 2002 and September of 2004. -
How Should the OB/GYN Doctor Dress for the Office?
These New Jersey authors hypothesized that attire and patient satisfaction would be unrelated. For 3 months, full-time faculty, both generalists and subspecialists, were randomly assigned to different attire, ie, business attire, casual clothing, or scrubs. -
Pharmacology Watch: Which Inhaler Combination is Best for COPD Treatment?
First Antihypertensive Drug Approved in Last 10 Years: Aliskiren; Alternate Treatment for Osteoporosis; Roche's Oseltamivir: Scrutiny, Bird Flu, and New Drug Applications; FDA Actions -
Clinical Briefs in Primary Care supplement